Suppr超能文献

细胞外基质蛋白通过 CAPG 减少心脏成纤维细胞在变硬微环境中的激活。

Exogenous extracellular matrix proteins decrease cardiac fibroblast activation in stiffening microenvironment through CAPG.

机构信息

Department of Biomedical Engineering, Case School of Engineering, Case Western Reserve University, Cleveland, OH, USA.

Department of Ophthalmology and Visual Sciences, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.

出版信息

J Mol Cell Cardiol. 2021 Oct;159:105-119. doi: 10.1016/j.yjmcc.2021.06.001. Epub 2021 Jun 10.

Abstract

Controlling fibrosis is an essential part of regenerating the post-ischemic heart. In the post-ischemic heart, fibroblasts differentiate to myofibroblasts that produce collagen-rich matrix to physically stabilize the infarct area. Infarct models in adult mice result in permanent scarring unlike newborn animals which fully regenerate. Decellularized extracellular matrix (dECM) hydrogels derived from early-aged hearts have been shown to be a transplantable therapy that preserves heart function and stimulates cardiomyocyte proliferation and vascularization. In this study, we investigate the anti-fibrotic effects of injectable dECM hydrogels in a cardiac explant model in the context of age-associated tissue compliance. Treatments with adult and fetal dECM hydrogels were tested for molecular effects on cardiac fibroblast activation and fibrosis. Altered sensitivity of fibroblasts to the mechanosignaling of the remodeling microenvironment was evaluated by manipulating the native extracellular matrix in explants and also with elastomeric substrates in the presence of dECM hydrogels. The injectable fetal dECM hydrogel treatment decreases fibroblast activation and contractility and lowers the stiffness-mediated increases in fibroblast activation observed in stiffened explants. The anti-fibrotic effect of dECM hydrogel is most observable at highest stiffness. Experiments with primary cells on elastomeric substrates with dECM treatment support this phenomenon. Transcriptome analysis indicated that dECM hydrogels affect cytoskeleton related signaling including Macrophage capping protein (CAPG) and Leupaxin (LPXN). CAPG was down-regulated by the fetal dECM hydrogel. LPXN expression was decreased by stiffening the explants; however, this effect was reversed by dECM hydrogel treatment. Pharmacological disruption of cytoskeleton polymerization lowered fibroblast activation and CAPG levels. Knocking down CAPG expression with siRNA inhibited fibroblast activation and collagen deposition. Collectively, fibroblast activation is dependent on cooperative action of extracellular molecular signals and mechanosignaling by cytoskeletal integrity.

摘要

控制纤维化是再生缺血性心脏的重要组成部分。在缺血性心脏中,成纤维细胞分化为肌成纤维细胞,产生富含胶原的基质,使梗死区物理稳定。成年小鼠的梗死模型导致永久性瘢痕,而新生动物则完全再生。从早期心脏中提取的去细胞细胞外基质(dECM)水凝胶已被证明是一种可移植的治疗方法,可保留心脏功能并刺激心肌细胞增殖和血管生成。在这项研究中,我们研究了可注射 dECM 水凝胶在与年龄相关的组织顺应性相关的心脏外植体模型中的抗纤维化作用。测试了成年和胎儿 dECM 水凝胶对心脏成纤维细胞激活和纤维化的分子作用。通过在外植体中操纵天然细胞外基质以及在存在 dECM 水凝胶的情况下使用弹性体底物来评估成纤维细胞对重塑微环境的机械信号的敏感性变化。可注射的胎儿 dECM 水凝胶处理降低了成纤维细胞的激活和收缩性,并降低了在变硬的外植体中观察到的刚度介导的成纤维细胞激活增加。在最高刚度下,dECM 水凝胶的抗纤维化作用最明显。在具有 dECM 处理的弹性体底物上进行的原代细胞实验支持了这一现象。转录组分析表明,dECM 水凝胶影响细胞骨架相关信号,包括巨噬细胞封顶蛋白(CAPG)和 Leupaxin(LPXN)。胎儿 dECM 水凝胶下调了 CAPG。通过使外植体变硬,LPXN 的表达减少;然而,这一效应被 dECM 水凝胶处理所逆转。细胞骨架聚合的药理学破坏降低了成纤维细胞的激活和 CAPG 水平。用 siRNA 敲低 CAPG 表达抑制了成纤维细胞的激活和胶原蛋白沉积。总之,成纤维细胞的激活依赖于细胞外分子信号的协同作用和细胞骨架完整性的机械信号。

相似文献

1
Exogenous extracellular matrix proteins decrease cardiac fibroblast activation in stiffening microenvironment through CAPG.
J Mol Cell Cardiol. 2021 Oct;159:105-119. doi: 10.1016/j.yjmcc.2021.06.001. Epub 2021 Jun 10.
3
Chemical Modification of Human Decellularized Extracellular Matrix for Incorporation into Phototunable Hybrid-Hydrogel Models of Tissue Fibrosis.
ACS Appl Mater Interfaces. 2023 Mar 29;15(12):15071-15083. doi: 10.1021/acsami.2c18330. Epub 2023 Mar 14.
4
Injectable Extracellular Matrix Microparticles Promote Heart Regeneration in Mice with Post-ischemic Heart Injury.
Adv Healthc Mater. 2022 Apr;11(8):e2102265. doi: 10.1002/adhm.202102265. Epub 2022 Feb 18.
6
Fibroblast alignment and matrix remodeling induced by a stiffness gradient in a skin-derived extracellular matrix hydrogel.
Acta Biomater. 2024 Jul 1;182:67-80. doi: 10.1016/j.actbio.2024.05.018. Epub 2024 May 13.
7
8
Decellularized heart ECM hydrogel using supercritical carbon dioxide for improved angiogenesis.
Acta Biomater. 2018 Feb;67:270-281. doi: 10.1016/j.actbio.2017.11.046. Epub 2017 Dec 6.
10
Engineering Hybrid-Hydrogels Comprised of Healthy or Diseased Decellularized Extracellular Matrix to Study Pulmonary Fibrosis.
Cell Mol Bioeng. 2022 Jun 24;15(5):505-519. doi: 10.1007/s12195-022-00726-y. eCollection 2022 Oct.

引用本文的文献

2
Tunable methacrylated decellularized heart matrix: a versatile scaffold for cardiac tissue engineering.
Front Bioeng Biotechnol. 2025 Jun 12;13:1579246. doi: 10.3389/fbioe.2025.1579246. eCollection 2025.
3
Runt-related transcription factors: from pathogenesis to therapeutic targets in multiple-organ fibrosis.
Front Cell Dev Biol. 2025 Apr 28;13:1528645. doi: 10.3389/fcell.2025.1528645. eCollection 2025.
4
Development of a decellularized extracellular matrix-derived wet adhesive for sustained drug delivery and enhanced wound healing.
Mater Today Bio. 2025 Apr 5;32:101734. doi: 10.1016/j.mtbio.2025.101734. eCollection 2025 Jun.
5
The considerations on selecting the appropriate decellularized ECM for specific regeneration demands.
Mater Today Bio. 2024 Oct 18;29:101301. doi: 10.1016/j.mtbio.2024.101301. eCollection 2024 Dec.
6
FYB1-targeted modulation of CAPG promotes AML progression.
Mol Cell Biochem. 2025 Feb;480(2):985-999. doi: 10.1007/s11010-024-04992-4. Epub 2024 May 3.
7
The Current State of Extracellular Matrix Therapy for Ischemic Heart Disease.
Med Sci (Basel). 2024 Jan 29;12(1):8. doi: 10.3390/medsci12010008.
9
mRNA therapy for myocardial infarction: A review of targets and delivery vehicles.
Front Bioeng Biotechnol. 2022 Nov 25;10:1037051. doi: 10.3389/fbioe.2022.1037051. eCollection 2022.
10
Preparation and Use of Decellularized Extracellular Matrix for Tissue Engineering.
J Funct Biomater. 2022 Nov 14;13(4):240. doi: 10.3390/jfb13040240.

本文引用的文献

1
2
Matrix stiffness controls cardiac fibroblast activation through regulating YAP via AT R.
J Cell Physiol. 2020 Nov;235(11):8345-8357. doi: 10.1002/jcp.29678. Epub 2020 Apr 2.
3
First-in-Man Study of a Cardiac Extracellular Matrix Hydrogel in Early and Late Myocardial Infarction Patients.
JACC Basic Transl Sci. 2019 Sep 11;4(6):659-669. doi: 10.1016/j.jacbts.2019.07.012. eCollection 2019 Oct.
4
Differentiating between Inactive and Active States of Rhodopsin by Atomic Force Microscopy in Native Membranes.
Anal Chem. 2019 Jun 4;91(11):7226-7235. doi: 10.1021/acs.analchem.9b00546. Epub 2019 May 16.
5
Matrix stiffness regulates microvesicle-induced fibroblast activation.
Am J Physiol Cell Physiol. 2019 Jul 1;317(1):C82-C92. doi: 10.1152/ajpcell.00418.2018. Epub 2019 Apr 24.
6
Mix and (mis-)match - The mechanosensing machinery in the changing environment of the developing, healthy adult and diseased heart.
Biochim Biophys Acta Mol Cell Res. 2020 Mar;1867(3):118436. doi: 10.1016/j.bbamcr.2019.01.017. Epub 2019 Feb 8.
10
Early Regenerative Capacity in the Porcine Heart.
Circulation. 2018 Dec 11;138(24):2798-2808. doi: 10.1161/CIRCULATIONAHA.117.031542.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验